Literature DB >> 6799481

SQ 26,776, a novel beta-lactam: an in-vitro comparison with other antimicrobial agents.

R Wise, J M Andrews, J Hancox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6799481     DOI： 10.1093/jac/8.suppl_e.39

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  16 in total

1.  Antibacterial activity of Ro 17-2301 and other antimicrobial agents against cefotaxime-resistant aerobic gram-negative bacilli.

Authors:  C A Benson; F E Walton; G M Trenholme
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

2.  In vitro activity of azthreonam and Ro 17-2301 against multiresistant Pseudomonas aeruginosa strains.

Authors:  P Campos; A Vera; F Martin-Luengo
Journal:  Eur J Clin Microbiol       Date:  1985-02       Impact factor: 3.267

3.  In vivo significance of the inoculum effect of antibiotics on Escherichia coli.

Authors:  F Soriano; M Santamaría; C Ponte; C Castilla; R Fernández-Roblas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

Review 4.  Seventy-Five Years of Research on Protein Binding.

Authors:  Axel Dalhoff
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

Review 5.  Mechanisms of resistance to cephalosporin antibiotics.

Authors:  D M Livermore
Journal:  Drugs       Date:  1987       Impact factor: 9.546

6.  In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli.

Authors:  M A Buesing; J H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

Review 7.  Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

8.  Evaluation of aztreonam in experimental bacterial meningitis and cerebritis.

Authors:  W M Scheld; J P Brodeur; J C Gratz; P Foresman; G Rodeheaver
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

9.  Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction.

Authors:  J C Mihindu; W M Scheld; N D Bolton; D A Spyker; E A Swabb; W K Bolton
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

10.  Enhancing effect of serum ultrafiltrate on the activity of cephalosporins against gram-negative bacilli.

Authors:  J E Leggett; W A Craig
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.